Merck V. Integra: (Section) 271(E) (1) and the Common Law Research Exemption. More Books Like This
HIF Bio, Inc. And Bizbiotech Co., Ltd., Plaintiffs-Appellees, V. Yung Shin Pharmaceuticals Industrial Co., Ltd. (Doing Business As Yung Shin Pharmaceuticals and Yung Shin Pharm. Ind. Co. Ltd.), Yung Zip Chemical Co., Ltd., Fang-Yu Lee, And Che-Ming Teng, Defendants, And Carlsbad Technology, Inc., Defendant-Appellant, And Fish and Richardson P.C., and Y. Rocky Tsao, Defendants (Case Overview)
2010
The Road Less Traveled: West Virginia's Rejection of the Learned Intermediary Doctrine in the Age of Direct-To-Consumer Advertising.
2009
The Physician's Immunity Statute: A Botched Operation Or a Model Procedure?
2009
Is the Quick-Look Antitrust Analysis in Polygram Holding Inherently Suspect?
2007
Qualified Appraisals and Qualified Appraisers
2017
Who's Liable Now?--New Federal Brownfields Legislation.
2003
Peer Review Immunity? Think Again: Recent Developments in Federal and State Law (Health Law Update)
2007
Creating R&D Incentives for Medicines for Neglected Diseases
2009
Sarbanes-Oxley: An Overview of Current Issues and Concerns.
2007
From Creditor to Debtor
2018
The Employment of Merchant Seamen
2017
Decision and risk at immigration service work
2014
A History of Greek Economic Thought
2019
Power Bases and Informational Influence Strategies
2008
Accounting for Derivatives (US-GAAP)
2003